ID NOW™ COVID-19 2.0 is a nucleic acid amplification test (NAAT), indicated for the qualitative detection of nucleic acid from SARS-CoV-2 in direct anterior nasal or nasopharyngeal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first seven days of the onset of symptoms. This isothermal molecular technology uses proprietary enzymes and constant temperature to achieve rapid amplification, with results in a fraction of the time it takes traditional molecular lab tests. Delivers reliable molecular results in just minutes, providing real-time access to the information needed to make actionable decisions right at the point of care. COVID-19 positive results in as early as 6 minutes; COVID-19 negative results in 12 minutes. PPA 93.3%, NPA 98.5%.